1. Home
  2. DVAX vs CVE Comparison

DVAX vs CVE Comparison

Compare DVAX & CVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$10.79

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Cenovus Energy Inc

CVE

Cenovus Energy Inc

HOLD

Current Price

$16.92

Market Cap

34.6B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
DVAX
CVE
Founded
1996
2009
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
34.6B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
DVAX
CVE
Price
$10.79
$16.92
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$26.50
$24.00
AVG Volume (30 Days)
1.5M
10.5M
Earning Date
11-05-2025
10-31-2025
Dividend Yield
N/A
3.01%
EPS Growth
N/A
N/A
EPS
N/A
1.23
Revenue
$330,514,000.00
$37,063,946,178.00
Revenue This Year
$24.63
N/A
Revenue Next Year
$15.85
N/A
P/E Ratio
N/A
$14.64
Revenue Growth
26.73
N/A
52 Week Low
$9.20
$10.23
52 Week High
$14.63
$18.75

Technical Indicators

Market Signals
Indicator
DVAX
CVE
Relative Strength Index (RSI) 48.33 39.36
Support Level $10.76 $17.43
Resistance Level $10.97 $18.06
Average True Range (ATR) 0.24 0.44
MACD -0.06 -0.11
Stochastic Oscillator 22.35 4.55

Price Performance

Historical Comparison
DVAX
CVE

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

About CVE Cenovus Energy Inc

Cenovus Energy Inc is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 786 thousand barrels of oil equivalent per day in 2022. The company had upstream projects across Western Canada; crude oil production and natural gas and NGLs production offshore China and Indonesia. The downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada.

Share on Social Networks: